Welcome Bibi!
Welcome Bibi! Bibi Subhan is rotating in our lab this fall!
Author Archive for: david.b.beck
Entries by David Beck
Our lab’s first paper!
We are excited to share that our lab’s first paper “Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis” is now published at Blood. Our work highlights a genotype-phenotype correlation in VEXAS syndrome based on levels of UBA1b translation. This was a tremendous collaboration with Drs. Achim Werner and Peter Grayson and a big congratulation to […]
Welcome Athena and Mary!
We are excited to welcome a new summer student, Athena Lam , and a research associate, Mary Likhite. We are excited to have both of you on the team!
New review from the lab- Disorders of ubiquitylation: unchained inflammation
We are proud to announce a new review from our lab and colleagues at the NIH in Nature Reviews Rheumatology. Here we outline immune dysregulation disorders caused by mutations in ubiquitylation enzymes and highlight how these shared mechanisms may lead to new treatments. Enjoy!
Relapsing Polychondritis Foundation Funding
We are thankful for the support of Relapsing Polychondritis Foundation! Our partnership is focused on better understanding Relapsing Polychondritis and VEXAS and helping provide new treatment insights into these diseases.
Our work profiled in the Hematologist!
Thank you for highlighting our work, and other researchers worldwide, in the Hematologist: ASH This Year’s Best in Hematology Diagnosis: A New Disease Is Discovered (here). It’s great to see increased recognition of this disease and our discoveries.
Welcome Anna!
The Beck lab welcomes Anna Cantor! Anna is a genetic counselor interested in clinical genetics and helping identify and characterize new genetic disorders.
Welcome Dinesh!
We are excited to welcome Dinesh Kumar as a post-doc in the lab. Glad to have you here!
Welcome Dinesh!
We are excited to have Dinesh join the group! Welcome to New York!
Dinesh joins the lab!
Dinesh joins the lab! We are very excited to have you here!
